OSIMERTINIB vs PALBOCICLIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
OSIMERTINIB vs PALBOCICLIB: Safety Overview
| Metric | OSIMERTINIB | PALBOCICLIB |
|---|---|---|
| Total FAERS Reports | 27,750 | 91,024 |
| Deaths Reported | 12,456 | 11,066 |
| Death Rate | 44.9% | 12.2% |
| Hospitalizations | 5,277 | 13,442 |
| Average Patient Age | 68.2 yrs | 66.0 yrs |
| % Female Patients | 66.0% | 97.7% |
| FDA Approval Date | Nov 13, 2015 | Feb 3, 2015 |
| Manufacturer | AstraZeneca Pharmaceuticals LP | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |